Human Papillomavirus Vaccine Increases High-Risk Sexual Behaviors: A Myth or Valid Concern

Journal of School Nursing

Volumn 30, Issue 6, 2014, Pages 456-463

  Ratanasiripong, Nop T ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

HPV vaccine; human papillomavirus; sexual behavior

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDY; FEMALE; HIGH RISK BEHAVIOR; HUMAN; PAPILLOMAVIRUS INFECTIONS; PSYCHOLOGY; QUESTIONNAIRE; SEXUAL BEHAVIOR; STATISTICS AND NUMERICAL DATA; STUDENT; UNITED STATES; UNIVERSITY; UNSAFE SEX; YOUNG ADULT;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RISK-TAKING; SEXUAL BEHAVIOR; STUDENTS; SURVEYS AND QUESTIONNAIRES; UNITED STATES; UNIVERSITIES; UNSAFE SEX; YOUNG ADULT;

EID: 84911109854     PISSN: 10598405     EISSN: 15468364     Source Type: Journal    
DOI: 10.1177/1059840513520042     Document Type: Article

References (35)

1. American College Health Association. (2010). National college health assessment: Spring 2010 reference group data report. Retrieved fromhttp://www.acha-ncha.org/docs/ACHA-NCHA-II_ReferenceGroup_ExecutiveSummary_Fall2010.pdf
2. Association of Reproductive Health Professionals. (2009). Managing HPV: A new era in patient care. Retrieved fromhttp://www.arhp.org/Publications-and-Resources/Quick-Reference-Guide-for-Clinicians/Managing-HPV
3. Ault K. A.Epidemiology and natural history of human Papillomavirus infections in the female genital tract.Infectious Disease in Obstetrics and Gynecology. 2006;40470:1-5
4. BaileyR. (2008). Safety, efficacy, morality, the FDA gets religion. Retrieved fromhttp://reason.com/archives/2005/11/04/safety-efficacy-morality
5. Health status survey report 2010. Long Beach, CA: Student Health Services; 2011:
6. Centers of Disease Control and Prevention. (2007). HPV information for clinicians. Retrieved fromhttp://www.cdc.gov/std/HPV/Provider6-2005/ApF1-DesignA.pdf
7. Centers of Disease Control and Prevention. (2010a). Morbidity and mortality weekly report: FDA licensure of bivalent Human Papillomavirus vaccine (HPV2, Cervarix) for use in females and undated HPV vaccination recommendations from the advisory committee on immunization practices (ACIP). Retrieved fromhttp://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm
8. Centers of Disease Control and Prevention. (2010b). National, state, and local area vaccination coverage among adolescents aged 13-17 years—United States, 2009. Morbidity and mortality weekly report (MMWR), 59, 1018–1023. Retrieved fromhttp://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm
9. Centers of Disease Control and Prevention. (2011). Statistics and surveillance: 2009 adult vaccination coverage, NHIS. Retrieved fromhttp://www.cdc.gov/vaccines/stats-surv/nhis/2009-nhis.htm
10. Centers of Disease Control and Prevention. (2013a). Incidence, prevalence, and cost of sexually transmitted infections in the United States. Retrieved fromhttp://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf
11. Centers of Disease Control and Prevention. (2013b). Genital HPV infection-fact sheet. Retrieved fromhttp://www.cdc.gov/std/hpv/stdfact-hpv.htm
12. Conroy K.,Rosenthal S. L.,Zimet G. D.,Jin Y.,Bernstein D. I.,Glynn S.,Kahn J. A.Human Papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination.Journal of Women’s Health. 2009;18:1679-1686
13. Dunne F. E.,Ungerer E. R.,Sternberg M.,McQuillan G.,Swan D. C.,Patel S. S.,Markowitz L. E.Prevalence of HPV infection among females in the United States.Journal of the American Medical Association. 2007;297:813-819
14. Field A.Discovering statistics using SPSS. 2009. Discovering statistics using SPSS (3rd ed.). Thousand Oaks, CA: Sage.Thousand Oaks, CA: Sage; 2009:
15. Frazer I. H.,Cox J. T.,Mayeaux E. J.,Franco E. L.,Moscicki A. B.,Palefsky J. M.,Villa L. L.Advances in prevention of cervical cancer and other Human Papillomavirus-related diseases.The Pediatric Infectious Disease Journal. 2006;25:S65-S81
16. Hager D. W.Human Papillomavirus infection and prevention in the adolescent population.Journal of Pediatric and Adolescent Gynecology. 2009;22:197-204
17. JohnsonW. A. (2011). How non-response bias can ruin your mail survey. Retrieved fromhttp://www.unsolicitedmarketingadvice.com/2007/07/02/how-non-response-bias-can-ruin-your-mail-survey/
18. Lahaut V. M.,Jansen H. A.,Mheen D. V,Garretsen H. F.Non-responses bias in a sample survey on alcohol consumption.Oxford Journals. 2002;3:256-260
19. Leech N. L.,Barrett K. C.,Morgan G. A.SPSS for intermediate statistics: Use and interpretation. 2008 SPSS for intermediate statistics: Use and interpretation (3rd ed.). New York, NY: Lawrence Erlbaum.New York, NY: Lawrence Erlbaum; 2008:
20. Licht A. S.,Murphy J. M.,Hyland A. J.,Fix B. V.,Hawk L. W.,Mahoney M. C.Is use of the Human Papillomavirus vaccine among female college students related to Human Papillomavirus knowledge and risk perception?.Sexually Transmitted Infection. 2010;86:74-78
21. Manhart L. E.,Burgess-Hull A. J.,Fleming C. B.,Bailey J. A.,Haggerty K. P.,Catalano R. F.HPV vaccination among a community sample of young adult women.Vaccine. 2011;29:5238-5244
22. Mullins T. L. K.,Zimet G. D.,Rosenthal S. L.,Morrow C.,Ding L.,Shew M.,Kahn J. A.Adolescent perceptions of risk and need for safer sexual behaviors after first human Papillomavirus vaccination.Archives of Pediatrics & Adolescent Medicine. 2012;166:82-88
23. Munoz N.,Bosch F. X.,de Sanjose S.,Herrero R.,Castellsaque X.,Snijders P. J.,Meijer C. J.Epidemiologic classification of human papillomavirus types associated with cervical cancer.New England Journal of Medicine. 2003;348:518-527
24. Ratanasiripong N.,Cheng A. L.,Enriquez M.What college women know, think, and do about Human Papillomavirus (HPV) and HPV vaccine.The Vaccine. 2013;31:3170-3176
25. Roberts M. E.,Gerrand M.,Reimer R.,Gibbons F. X.Mother-daughter communication and Human Papillomavirus vaccine update by college students.Pediatrics. 2010;125:982-989
26. Rothman S. M.,Rothman D. J.Marketing HPV vaccine: Implications for adolescent health and medical professionalism.Journal of the American Medical Association. 2009;302:781-786
27. Santelli J. S.,Brener N. D.,Lowry R.,Bhatt A.,Zabin L. S.Multiple sexual partners among U.S. adolescents and young adults.Family Planning Perspectives. 1998;30:271-275
28. Sax L. J.,Gilmartin S. K.,Bryant A. N.Assessing response rates and nonresponse bias in web and paper surveys.Research in Higher Education. 2003;44:409-432
29. Stanley M.Pathology and epidemiology of HPV infection in females.Gynecological Oncology. 2010;117:S5-S10
30. Thomas T. L.The new human papillomavirus (HPV) vaccine: Pros and cons for pediatric and adolescent health.Pediatrics Nursing. 2008;34:429-431
31. U.S. Food and Drug Administration. (2010). FDA: Gardasil approved to prevent anal cancer. Retrieved fromhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm237941.htm
32. Vamos C. A.,McDermott R. J.,Daley E. M.The HPV vaccine: Framing the arguments for and against mandatory vaccination of all middle school girls.Journal of School Health. 2008;78:302-309
33. Weinstock H.,Berman S.,Cates J. W.Sexually transmitted diseases among American youth: Incidence and prevalence estimates.Perspectives on Sexual and Reproductive Health. 2004;36:6-10
34. Winer R. L.,Hughes J. P.,Feng Q.,O’Reilly S.,Kiviat N. B.,Holmes K. K.,Koutsky L. A.Condom use and the risk of genital Human Papillomavirus infection in young women.New England Journal of Medicine. 2006;354:2645-2654
35. World Health Organization. (2006). New vaccines against cervical cancer major opportunity for developing world. Retrieved fromhttp://www.who.int/mediacentre/news/releases/2006/pr73/en/